Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

UBS vs NEWTI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

UBS Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

UBS Overall Winner 6-Pillar Tally: UBS 5 – 1 NEWTI Matrix Metrics: UBS 7 – 3 NEWTI

As of Nov 20, 2026, UBS Group AG (UBS) is the stronger overall head-to-head candidate over NewtekOne, Inc. 8.00% Fixed Rate Senior Notes due 2028 (NEWTI) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). UBS carries a Unified Composite Score of 49.3/100 (HOLD) at $43.32 (10.1x Forward P/E, 31.8% operating margin), whereas NEWTI carries 51.8/100 (HOLD) at $25.24 (N/M Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While NEWTI currently prints a higher short-term Unified Composite Score (51.8/100 HOLD vs. UBS 49.3/100 HOLD), UBS captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (31.8% vs. 0.0% operating margin) and revenue trajectory (+11.9% vs. +0.0% YoY).
  • Technical & Structure Timing Caution: UBS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.2); meanwhile NEWTI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About UBS vs NEWTI
UBS NYSE Head-to-Head Winner
UBS Group AG
National Commercial Banks
$43.32
-3.78% 1D
Market Cap $136.4B
TTM Revenue $54.6B
Forward P/E 10.1x
Beta / 30D Vol 1.25β · 34% Vol
Unified Composite Score
49.3 / 100 HOLD
Tech 16.0 Fund 41.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.3%), weak momentum, RSI 30
RSI-14: 30.2 · SMA20: $47.59 · SMA50: $48.16
NEWTI NASDAQ
NewtekOne, Inc. 8.00% Fixed Rate Senior Notes due 2028
National Commercial Banks
$25.24
+0.52% 1D
Market Cap $426.2M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.04β · 6% Vol
Unified Composite Score
51.8 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 50.0 Mom 70.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 51.2 · SMA20: $25.22 · SMA50: $25.15

6-Pillar Scorecard Institutional Category Breakdown (UBS 5 – 1 NEWTI)

Columns: Metric · UBS · NEWTI
1. Valuation Multiples UBS
Forward P/E 10.1x N/M
Trailing P/E 14.9x N/M
PEG Ratio 0.67x N/M
EV / Revenue 4.9x N/M
2. Growth & Scale UBS
Revenue Growth (YoY) +11.9% +0.0%
Earnings Growth (YoY) +11.2% +0.0%
TTM Revenue (USD) $54.6B N/A
Market Cap $136.4B $426.2M
3. Profitability & Quality UBS
Gross Margin 100.0% N/A
Operating Margin 31.8% 0.0%
Net Profit Margin 17.8% 0.0%
Return on Equity (ROE) 10.9% 0.0%
4. Balance Sheet & Cash Flow NEWTI
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $129.1B Net Debt (3.67x D/E) 0.0% ROE
Dividend Yield 2.41% None (0.00%)
5. Options & Positioning UBS
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 31.0% (58th %ile) N/A (N/A)
Put/Call OI Skew 4.17x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat UBS
OpEx & R&D Intensity 68.2% of Rev ($37.2B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Banks - Diversified Operator Other Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: UBS (7) vs NEWTI (3)
Institutional Metric UBS NEWTI Criterion Row Edge
Market Capitalization
Scale
$136.4B $426.2M Larger Scale UBS
Trailing P/E Ratio
Valuation
14.9x N/M Lower Multiple UBS
Forward P/E Ratio
Valuation
10.1x N/M Lower Multiple UBS
Revenue Growth (YoY)
Growth
+11.9% +0.0% Higher Growth UBS
Operating Margin (TTM)
Profitability
31.8% 0.0% Higher Margin UBS
Net Profit Margin
Profitability
17.8% 0.0% Higher Margin UBS
Return on Equity (ROE)
Capital Efficiency
10.9% 0.0% Higher ROE UBS
52-Week Range Position
Momentum
36% ($36–$56) 66% ($24–$26) Stronger Trend NEWTI
Beta / 30D Volatility
Risk Regime
1.25β · 34% Vol 0.04β · 6% Vol Lower Realized Risk NEWTI
Unified Institutional Score
Composite Signal
49.3 / 100 (HOLD) 51.8 / 100 (HOLD) Higher Composite NEWTI
Trailing 12M Revenue (USD)
Operating Scale
$54.6B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.67x PEG · 4.9x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($129.1B Net Debt (3.67x D/E)) N/A (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NEWTI +9.8 pp
UBS: -9.62% · NEWTI: +0.18%
3M Horizon NEWTI +17.73 pp
UBS: -18.94% · NEWTI: -1.21%
6M Horizon UBS +1.79 pp
UBS: +1.4% · NEWTI: -0.39%
1Y Horizon UBS +12.84 pp
UBS: +13.4% · NEWTI: +0.56%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UBS vs NEWTI. Trailing 12-month operating profitability (UBS 31.8% vs NEWTI 0.0%) and valuation multiples (UBS 10.1x vs NEWTI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

UBS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$54.6B
Gross Margin100.0%
Op. Margin31.8%
ROE / Fwd P/E10.9% · 10.1x
NEWTI ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
UBS CONSOLIDATION
107d in phase · OBV DISTRIBUTION
Current IV 31.0%
IV Percentile 58th %ile
Put/Call OI Skew 4.17x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact UBS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NEWTI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NEWTI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $47.61 · IV 28.6%

UBS Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($4,761)

Compare $4,761 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 28.6% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $47.5 / $50 Bull Call Spread

Buy 1x $47.5C · Sell 1x $50C · 32d

Net Entry $117 Debit
T+5d @ +5% Move +$53 (+46%)
Max Risk / Buffer $117 Capped
5d Edge & Liquidity 0.8x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $45 / $42.5 Bull Put Spread

Sell 1x $45P · Buy 1x $42.5P · 32d

Net Entry $30 Credit
Max Credit / Yield +$30 (+13.6% RoM)
Max Risk / Buffer -6.1% Cushion ($220 Mgn)
5d Edge & Liquidity 77% PoP · Liq B
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq C

Dec 18 $45P / $47.5-$50C Seagull

Sell 1x $45P · Buy 1x $47.5/$50C · 32d

Net Entry $62 Debit
T+5d @ +5% Move +$97 (+12.0% RoM)
Max Risk / Buffer -5.5% Put Cushion ($808 Mgn)
5d Edge & Liquidity 0.6x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
UBS Moat Profile High-Margin Pricing Power Moat
Banks - Diversified Operator
Competes within the Banks - Diversified value chain with $136.4B market capitalization and 31.8% operating margin.
OpEx & R&D Reinvestment 68.2% of Rev ($37.2B)
90D Engineering Disclosures 0 Published
NEWTI Moat Profile Cyclical / Execution-Driven Positioning
Other Operator
Competes within the Other value chain with $426.2M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ UBS vs NEWTI Key Questions & Quantitative Answers

As of Nov 20, 2026, UBS Group AG (UBS) is the stronger overall head-to-head candidate over NewtekOne, Inc. 8.00% Fixed Rate Senior Notes due 2028 (NEWTI) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). UBS carries a Unified Composite Score of 49.3/100 (HOLD) at $43.32 (10.1x Forward P/E, 31.8% operating margin), whereas NEWTI carries 51.8/100 (HOLD) at $25.24 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While NEWTI currently prints a higher short-term Unified Composite Score (51.8/100 HOLD vs. UBS 49.3/100 HOLD), UBS captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (31.8% vs. 0.0% operating margin) and revenue trajectory (+11.9% vs. +0.0% YoY). Technical & Structure Timing Caution: UBS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.2); meanwhile NEWTI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

UBS leads the Growth & Scale pillar: UBS posts +11.9% YoY revenue growth and +11.2% YoY earnings growth on $54.6B TTM revenue (100.0% gross margin, 31.8% operating margin), compared with NEWTI at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, UBS generates $54.6B in USD-normalized revenue versus N/A for NEWTI. In operating R&D and SG&A reinvestment, UBS deploys 68.2% of Rev ($37.2B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NEWTI.

UBS screens cheaper on headline valuation multiples. UBS trades at 10.1x Forward P/E, 14.9x Trailing P/E, 0.67x PEG, and 4.9x EV/Revenue (unreported cash flow margin), whereas NEWTI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against UBS (10.9% ROE) versus NEWTI (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, UBS carries 31.0% implied volatility (58th %ile, Balanced (25th–60th %ile)), a 4.17x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.25β · 34% Vol realized risk). By comparison, NEWTI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 6% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.